Qibing Xie

机构：Sichuan University, West China Hospital of Sichuan University, People's Hospital of Xinjiang Uygur Autonomous Region · ORCID：0000-0002-6727-1839

发表论文 128 篇 · 总被引 1689 次 · h-index 23

代表论文

• Single cell immunoprofile of synovial fluid in rheumatoid arthritis with TNF/JAK inhibitor treatment (2025 · Nature Communications · 被引 56)
• Systemic immune-inflammation index as a versatile biomarker in autoimmune disorders: insights from rheumatoid arthritis, lupus, and spondyloarthritis (2025 · Frontiers in Immunology · 被引 35)
• Macrophage-derived mir-100-5p orchestrates synovial proliferation and inflammation in rheumatoid arthritis through mTOR signaling (2024 · Journal of Nanobiotechnology · 被引 35)
• Augmenting regulatory T cells: new therapeutic strategy for rheumatoid arthritis (2024 · Frontiers in Immunology · 被引 27)
• Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial (2025 · Annals of the Rheumatic Diseases · 被引 22)
• Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments (2024 · Journal of Autoimmunity · 被引 18)